Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Summary
To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).
Official title: EROS 3 Study Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy Brachytherapy in Terms of Overall Toxicity and Sexual Activity
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
129
Start Date
2024-05-06
Completion Date
2026-12-30
Last Updated
2025-08-15
Healthy Volunteers
Yes
Conditions
Interventions
Interventional Radiotherapy
The patients will undergo four IRT fractions in one week
Locations (1)
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Rome, Italy